134 related articles for article (PubMed ID: 3467026)
1. How sensitive are the commercial assays for anti-HTLV III/LAV?
Oldham LJ; Moulsdale HJ; Mortimer PP; Tedder RS; Morgan-Capner P
J Med Virol; 1987 Jan; 21(1):75-9. PubMed ID: 3467026
[TBL] [Abstract][Full Text] [Related]
2. Detection of HTLV-III antibody in cerebrospinal fluid from patients with AIDS and pre-AIDS with the use of a commercial test system.
Johnson JE; Zolla-Pazner S
Am J Clin Pathol; 1987 Sep; 88(3):351-3. PubMed ID: 3477084
[TBL] [Abstract][Full Text] [Related]
3. [Comparison of two ELISA kits for the demonstration of antibodies against LAV/HTLV-III].
Heinz FX; Kunz C; Barrett N
Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Apr; 264(1-2):196-200. PubMed ID: 3307232
[TBL] [Abstract][Full Text] [Related]
4. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
Abb J
AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
[TBL] [Abstract][Full Text] [Related]
5. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
[TBL] [Abstract][Full Text] [Related]
6. Specificity of human immunodeficiency virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania.
Schüpbach J; Tanner M
Acta Trop; 1986 Sep; 43(3):195-206. PubMed ID: 2877546
[TBL] [Abstract][Full Text] [Related]
7. Screening for anti-HTLV-III/LAV antibody in high-risk subjects: sensitivity and specificity of commercial tests.
Lantin JP; Peitrequin R; Frei PC
Int Arch Allergy Appl Immunol; 1987; 82(3-4):487-9. PubMed ID: 3553029
[TBL] [Abstract][Full Text] [Related]
8. [HIV (HTLV III/LAV) serology: experiences based on more than 42,000 tests].
Gschnait F; Schmidt BL; Schwarz T; Heinz FX; Kunz C
Wien Klin Wochenschr; 1987 Aug; 99(15):536-9. PubMed ID: 3310415
[TBL] [Abstract][Full Text] [Related]
9. Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood.
Esteban JI; Shih JW; Tai CC; Bodner AJ; Kay JW; Alter HJ
Lancet; 1985 Nov; 2(8464):1083-6. PubMed ID: 2865566
[TBL] [Abstract][Full Text] [Related]
10. Sensitivity and specificity of commercial ELISA kits for screening anti-LAV/HTLV III.
Gürtler LG; Eberle J; Lorbeer B; Deinhardt F
J Virol Methods; 1987 Jan; 15(1):11-23. PubMed ID: 3468119
[TBL] [Abstract][Full Text] [Related]
11. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
[TBL] [Abstract][Full Text] [Related]
12. [Value of ELISA in the diagnosis of HTLV-III-LAV infection. Specificity of kits].
Lazizi Y; Guetard D; Pillot J
Presse Med; 1986 Dec; 15(43):2169. PubMed ID: 2954072
[No Abstract] [Full Text] [Related]
13. Comparison of two commercially available anti-HIV ELISAs: Abbott HTLV III EIA and Du Pont HTLV III-ELISA.
Burkhardt U; Mertens T; Eggers HJ
J Med Virol; 1987 Nov; 23(3):217-24. PubMed ID: 3323415
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of serological cross-reactivity between antibodies to Plasmodium and HTLV-III/LAV.
Greenberg AE; Schable CA; Sulzer AJ; Collins WE; Phuc Nguyen-Dinh
Lancet; 1986 Aug; 2(8501):247-9. PubMed ID: 2874279
[TBL] [Abstract][Full Text] [Related]
15. [Detection of antibodies to HTLV-III: a comparison of various ELISA methods as screening tests and the Western Blot with immunofluorescence as confirmatory procedures].
Hengster P; Larcher C; Pöckl E; Schulz T; Wachter H; Dierich MP
Wien Klin Wochenschr; 1987 Feb; 99(4):112-4. PubMed ID: 3554776
[TBL] [Abstract][Full Text] [Related]
16. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a new confirmatory assay for antibodies against lymphadenopathy-associated virus (LAV)/human T-lymphotropic virus type III (HTLV III).
Abb J
Vox Sang; 1986; 51(3):233-5. PubMed ID: 3544497
[TBL] [Abstract][Full Text] [Related]
18. Enzyme immunoassays for the demonstration of antibodies to HIV-2SBL-6669 and HTLV-IV (SIVmac).
Biberfeld G; Thorstensson R; Bergström M; Naucler A; Costa CM
AIDS; 1988 Jun; 2(3):195-9. PubMed ID: 3134913
[TBL] [Abstract][Full Text] [Related]
19. An immunoglobulin G capture assay (GACRIA) for anti-HTLV III/LAV and its use as a confirmatory test.
Parry JV
J Med Virol; 1986 Aug; 19(4):387-97. PubMed ID: 3018141
[TBL] [Abstract][Full Text] [Related]
20. High prevalence and high titers of LAV/HTLV-III antibodies in healthy hemophiliacs in the midwestern United States.
Goldsmith JC; Dewhurst S; Hedenskog M; Casareale D; Volsky DJ
Am J Med; 1986 Oct; 81(4):579-83. PubMed ID: 3532787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
